GlaxoSmithKline Pharmaceuticals logo

GlaxoSmithKline Pharmaceuticals MD, chairman, board of directors and AGM

NSE: GLAXOBSE: 500660Pharmaceuticals & BiotechnologyMid Cap

Formerly Glaxo (India)
Last close ₹2,404.70down ₹29.00 (1.19%)BSE ₹2,404.80

Share price at the NSE close on 23 Oct 2026. Previous close ₹2,433.70.

52-week range of traded prices to 23 Oct 2026
₹2,088.10Low, 12 Jun 2026₹3,120.70High, 28 Aug 2026
Market cap
₹40,737 Cr221st largest listed
P/E
38.1
P/B
18.0
Dividend yield
2.37%
ROE
50.6%
ROCE
56.3%
Debt to equity
0.00
Volume, NSE
56,17458.6% delivered

GlaxoSmithKline Pharmaceuticals board of directors

At the end of the quarter to Jun 2026, as the company filed it; changes since are in its announcements.Their trades in its shares

  • ChairpersonRenu Sud Karnad
  • Company Secretary and Compliance OfficerAjay Nadkarni

8 directors4 independent2 executive2 non-executive

  • Renu Sud Karnad · ChairpersonNon-executive · joined Apr 2019 · 5 listed boards · 1 as independent · 8 committee seats, 2 as chair
  • Sunita MaheshwariIndependent · joined May 2020 · reappointed May 2025 · 73 months as independent · 2 listed boards · 2 as independent · 1 committee seat
  • Manu AnandIndependent · joined May 2022 · reappointed May 2022 · 46 months as independent · 2 listed boards · 2 as independent · 2 committee seats
  • Somasundaram PalamadairamaswamyIndependent · joined Mar 2025 · reappointed Mar 2025 · 15 months as independent · 2 listed boards · 2 as independent · 3 committee seats, 2 as chair
  • Anup WadhawanIndependent · joined Mar 2025 · reappointed Mar 2025 · 15 months as independent · 4 listed boards · 3 as independent · 6 committee seats, 3 as chair
  • Bhushan AkshikarExecutive · joined Dec 2022 · 1 listed board · 1 as independent · 1 committee seat
  • Ronojit BiswasExecutive · joined Apr 2026 · 1 listed board · 1 as independent
  • Subesh WilliamsNon-executive · joined Apr 2017 · 1 listed board · 1 as independent

An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.

1 director who left
  • Juby Chandy, left 11 Mar 2026: Others

Committees and meetings

Who sits on each, and how often they met.Board meeting notices and outcomes

  • Board

    • 13 May 20268 of 8 present4 independent · 71 days in between
    • 2 Mar 20268 of 8 present4 independent · 20 days in between
    • 9 Feb 20268 of 8 present4 independent

  • Audit Committee

    Chair Somasundaram Palamadairamaswamy

    Manu Anand, Renu Sud Karnad

    • 13 May 20263 of 3 present2 independent · 71 days in between
    • 2 Mar 20263 of 3 present2 independent · 20 days in between
    • 9 Feb 20263 of 3 present2 independent

  • Nomination and remuneration committee

    Chair Manu Anand

    Anup Wadhawan, Renu Sud Karnad

    • 2 Mar 20263 of 3 present2 independent · 20 days in between
    • 9 Feb 20263 of 3 present2 independent

  • Stakeholders Relationship Committee

    Chair Renu Sud Karnad

    Bhushan Akshikar, Sunita Maheshwari

    • 9 Feb 20263 of 3 present2 independent

  • Risk Management Committee

    Chair Somasundaram Palamadairamaswamy

    Manu Anand, Renu Sud Karnad

    • 9 Feb 20263 of 3 present2 independent

  • Corporate Social Responsibility Committee

    Chair Sunita Maheshwari

    Bhushan Akshikar, Anup Wadhawan

    • 18 Jun 20263 of 3 present2 independent · 128 days in between

Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.

Statutory auditor

Named in the results for the quarter to Mar 2026.

  • M/s Deloitte Haskins & SellsPeer-review certificate valid to Jul 2027
1 earlier auditor
  • M/s Deloitte Haskins & Sells LLPNamed in the filing for the quarter to Mar 2025

A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.

GlaxoSmithKline Pharmaceuticals AGM and shareholder votes

Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.GlaxoSmithKline Pharmaceuticals dividend history

Postal ballot, 13 Sep 2026

1,27,764 shareholders on the register on 7 Aug 2026; votes counted by P.N.Parikh / Parikh & Associates.The company's voting result (opens in a new tab)

  1. Appointment of Ms. Karine J F Natland (DIN:11870917) as a Non-Executive Director
    Ordinary
    99.71% for0.29% against

    Against: promoters 0.00% · institutions 2.54% · other public 4.22%

    Turnout: all 84.70% · promoters 100.00% · institutions 75.14% · other public 0.48%

  2. Re-appointment of Mr. Bhushan Akshikar (DIN: 09112346) as Managing Director
    Ordinary
    99.71% for0.29% against

    Against: promoters 0.00% · institutions 2.53% · other public 3.24%

    Turnout: all 84.67% · promoters 100.00% · institutions 74.93% · other public 0.48%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 30 Jun 2026, 6 resolutions

1,32,132 shareholders on the register on 23 Jun 2026; present: 4 promoters and 52 others; votes counted by P.N. Parikh / Parikh & Asscoiates.The company's voting result (opens in a new tab)

  1. To receive, consider and adopt the Audited Financial Statements (including Consolidated Financial Statements) of the Company for the financial year ended 31st March 2026, together with the Reports of the Board of Directors and Auditors thereon.MoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 1.00%

    Turnout: all 84.04% · promoters 100.00% · institutions 71.79% · other public 0.33%

  2. To declare Dividend of Rs. 57 per share on Equity Shares for the financial year ended 31st March 2026.
    Ordinary
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.10% · other public 0.97%

    Turnout: all 84.12% · promoters 100.00% · institutions 72.46% · other public 0.34%

  3. To appoint a Director, in place of Mr. Subesh Williams (DIN: 07786724), who retires by rotation and being eligible, offers himself for re-appointment.
    Ordinary
    99.48% for0.52% against

    Against: promoters 0.00% · institutions 4.76% · other public 8.78%

    Turnout: all 84.12% · promoters 100.00% · institutions 72.46% · other public 0.34%

  4. Commission to Independent Directors
    Special
    99.96% for0.04% against

    Against: promoters 0.00% · institutions 0.31% · other public 11.25%

    Turnout: all 84.12% · promoters 100.00% · institutions 72.46% · other public 0.33%

  5. Ratification of Remuneration to Cost Auditor for Financial Year ended 31st March 2026
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 6.92%

    Turnout: all 84.12% · promoters 100.00% · institutions 72.46% · other public 0.34%

  6. Ratification of Remuneration to Cost Auditor for Financial Year ended 31st March 2027
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 6.79%

    Turnout: all 84.12% · promoters 100.00% · institutions 72.46% · other public 0.33%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 8 Apr 2026, 2 resolutions

1,26,273 shareholders on the register on 27 Feb 2026; votes counted by P.N.Parikh / Parikh & Associates.The company's voting result (opens in a new tab)

  1. Appointment of Mr. Ronojit Biswas (DIN 07684843) as a Director
    Ordinary
    99.69% for0.31% against

    Against: promoters 0.00% · institutions 2.89% · other public 2.60%

    Turnout: all 84.04% · promoters 100.00% · institutions 73.04% · other public 0.42%

  2. Appointment of Mr. Ronojit Biswas (DIN: 07684843) as a Whole-time Director and Chief Financial Officer (CFO)
    Ordinary
    99.76% for0.24% against

    Against: promoters 0.00% · institutions 2.26% · other public 2.69%

    Turnout: all 84.04% · promoters 100.00% · institutions 73.04% · other public 0.42%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 27 Jun 2025, 6 resolutions

1,29,301 shareholders on the register on 20 Jun 2025; present: 4 promoters and 77 others; votes counted by P.N. Parikh / Parikh & Asscoiates.The company's voting result (opens in a new tab)

  1. To receive, consider and adopt the Audited Financial Statements (including Consolidated Financial Statements) of the Company for the financial year ended March 31, 2025 together with the Reports of the Board of Directors and Auditors thereon.MoreLess
    Ordinary
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.08% · other public 0.45%

    Turnout: all 84.44% · promoters 100.00% · institutions 74.57% · other public 0.66%

  2. To confirm the payment of Interim Dividend on Equity Shares and declare Final Dividend of Rs 42 per share on Equity Shares for the financial year ended March 31, 2025
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.45%

    Turnout: all 84.55% · promoters 100.00% · institutions 75.44% · other public 0.66%

  3. To appoint a Director, in place of Mr. Juby Chandy (DIN:09530618), who retires by rotation and being eligible, offers himself for re-appointment.
    Ordinary
    99.63% for0.37% against

    Against: promoters 0.00% · institutions 3.27% · other public 0.74%

    Turnout: all 84.54% · promoters 100.00% · institutions 75.44% · other public 0.64%

  4. Re-Appointment of Dr. (Ms.) Sunita Maheshwari, (DIN 01641411) as an Independent Director
    Special
    98.30% for1.70% against

    Against: promoters 0.00% · institutions 15.20% · other public 1.84%

    Turnout: all 84.54% · promoters 100.00% · institutions 75.44% · other public 0.64%

  5. Appointment of Secretarial Auditors of the Company.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 1.37%

    Turnout: all 84.54% · promoters 100.00% · institutions 75.43% · other public 0.64%

  6. Ratification of Remuneration to Cost Auditor
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 1.44%

    Turnout: all 84.54% · promoters 100.00% · institutions 75.44% · other public 0.64%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 29 Apr 2025, 3 resolutions

1,27,195 shareholders on the register on 21 Mar 2025; votes counted by P.N. Parikh / Parikh & Asscoiates.The company's voting result (opens in a new tab)

  1. Re-Appointment of Mr. Juby Chandy (DIN:09530618) as a Whole-time Director & Chief Financial Officer (CFO)
    Ordinary
    99.82% for0.18% against

    Against: promoters 0.00% · institutions 1.73% · other public 2.99%

    Turnout: all 83.88% · promoters 100.00% · institutions 71.97% · other public 0.47%

  2. Appointment of Mr. Somasundaram Palamadairamaswamy (DIN: 00356363) as an Independent Director
    Special
    99.94% for0.06% against

    Against: promoters 0.00% · institutions 0.51% · other public 2.69%

    Turnout: all 83.88% · promoters 100.00% · institutions 71.97% · other public 0.47%

  3. Appointment of Mr. Anup Wadhawan (Din: 03565167)as an Independent Director
    Special
    99.92% for0.08% against

    Against: promoters 0.00% · institutions 0.71% · other public 3.08%

    Turnout: all 83.88% · promoters 100.00% · institutions 71.97% · other public 0.47%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 28 Jun 2024, 5 resolutions

Present: 4 promoters and 68 others.The company's voting result (opens in a new tab)

  1. ORDINARY - To receive, consider and adopt the Audited Financial Statements (including Consolidated Financial Statements) of the Company for the financial year ended 31 March 2024 together with the Reports of the Board of Directors and Auditors thereon.MoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.30%

    Turnout: all 82.99% · promoters 100.00% · institutions 69.01% · other public 0.33%

  2. To declare Rs 32 per share Dividend on Equity Shares for the financial year ended 31 March 2024.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.59%

    Turnout: all 83.01% · promoters 100.00% · institutions 69.19% · other public 0.33%

  3. To appoint a Director in place of Mr. Subesh Williams (DIN: 07786724), who retires by rotation and being eligible, offers himself for re-appointment.
    Ordinary
    98.96% for1.04% against

    Against: promoters 0.00% · institutions 10.85% · other public 1.24%

    Turnout: all 83.01% · promoters 100.00% · institutions 69.18% · other public 0.33%

  4. Appointment of Ms. Renu Sud Karnad as Non- Executive Director (DIN:00008064)
    Ordinary
    96.63% for3.37% against

    Against: promoters 0.00% · institutions 35.13% · other public 1.27%

    Turnout: all 83.01% · promoters 100.00% · institutions 69.18% · other public 0.33%

  5. Ratification of Remuneration to Cost Auditor.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 2.95%

    Turnout: all 83.01% · promoters 100.00% · institutions 69.18% · other public 0.33%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 26 Jul 2023, 4 resolutions

Present: 4 promoters and 68 others.The company's voting result (opens in a new tab)

  1. To receive, consider and adopt the Audited Financial Statements.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.20%

    Turnout: all 84.91% · promoters 100.00% · institutions 78.05% · other public 0.38%

  2. To declare Dividend on Equity Shares for the financial year ended 31 March 2023.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.21%

    Turnout: all 84.91% · promoters 100.00% · institutions 78.05% · other public 0.38%

  3. To appoint a Director in place of Mr. Juby Chandy (DIN:09530618), who retires by rotation and being eligible, offers himself for re-appointment.
    Ordinary
    99.18% for0.82% against

    Against: promoters 0.00% · institutions 7.02% · other public 2.71%

    Turnout: all 84.91% · promoters 100.00% · institutions 78.05% · other public 0.38%

  4. Ratification of Remuneration to Cost Auditor.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 2.29%

    Turnout: all 84.91% · promoters 100.00% · institutions 78.05% · other public 0.38%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 29 Nov 2022, 2 resolutions

The company's voting result (opens in a new tab)

  1. Appointment of Mr. Bhushan Akshikar (DIN: 09112346) as a Director
    Ordinary
    99.48% for0.52% against

    Against: promoters 0.00% · institutions 3.97% · other public 6.70%

    Turnout: all 86.33% · promoters 100.00% · institutions 89.18% · other public 0.29%

  2. Appointment of Mr. Bhushan Akshikar (DIN: 09112346) as a Managing Director
    Ordinary
    98.03% for1.97% against

    Against: promoters 0.00% · institutions 15.00% · other public 6.61%

    Turnout: all 86.33% · promoters 100.00% · institutions 89.18% · other public 0.29%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

How mutual funds voted

Fund houses must disclose how they vote at every meeting of a company they hold.Funds that hold it

Mutual fund votes, meeting of 13 Sep 2026, 12 fund houses so far (houses' deadline to file 15 Oct 2026)

  • Appointment of Ms. Karine J F Natland (DIN:11870917) as a Non-Executive Director
    12 for0 against
  • Re-appointment of Mr. Bhushan Akshikar (DIN: 09112346) as Managing Director
    Against Angel One Mutual Fund, Navi Mutual Fund
    • Angel One Mutual FundGovernance and transparency concern: The Company has not disclosed if the office of the proposed appointee is liable to retire by rotation or not, whereas the past indicates that he has been non-retiring. If his proposed tenure is non-retiring, the Board of the Company will be non-compliant with Section 152(6)(a) of the Companies Act as well as the AOA of the Company. Further, the proposed remuneration includes share-based benefits, however, the Company has not placed any absolute cap on such benefits; effectively, there is no cap on total remuneration payable to the director.
    • Navi Mutual FundCompliant with law. No concern identified with regard to profile, merit and time commitment of the proposed appointee. Governance and transparency concern: The Company has not disclosed if the office of the proposed appointee is liable to retire by rotation or not, whereas the past indicates that he has been non-retiring. If his proposed tenure is non-retiring, the Board of the Company will be noncompliant with Section 152(6)(a) of the Companies Act as well as the AOA of the Company. Further, the proposed remuneration includes share-based benefits, however, the Company has not placed any absolute cap on such benefits; effectively, there is no cap on total remuneration payable to the director.
    10 for2 against

Mutual fund votes, meeting of 30 Jun 2026, 26 fund houses

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

  • To receive, consider and adopt the Audited Financial Statements (including Consolidated Financial Statements) of the Company for the financial year ended 31st March 2026, together with the Reports of the Board of Directors and Auditors thereon.MoreLess
    25 for0 against
  • To declare Dividend of Rs. 57 per share on Equity Shares for the financial year ended 31st March 2026.
    25 for0 against
  • To appoint a Director, in place of Mr. Subesh Williams (DIN: 07786724), who retires by rotation and being eligible, offers himself for re-appointment.
    26 for0 against
  • Commission to Independent Directors
    26 for0 against
  • Ratification of Remuneration to Cost Auditor for Financial Year ended 31st March 2026
    25 for0 against
  • Ratification of Remuneration to Cost Auditor for Financial Year ended 31st March 2027
    25 for0 against
4 proposals not matched to one resolution
  • Item 1, as a fund house numbered it
    1 for0 against
  • Item 2, as a fund house numbered it
    1 for0 against
  • Item 5, as a fund house numbered it
    1 for0 against
  • Item 6, as a fund house numbered it
    1 for0 against
6 earlier meetings

Mutual fund votes, meeting of 8 Apr 2026, 27 fund houses

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

  • Appointment of Mr. Ronojit Biswas (DIN 07684843) as a Director
    26 for0 against
  • Appointment of Mr. Ronojit Biswas (DIN: 07684843) as a Whole-time Director and Chief Financial Officer (CFO)
    27 for0 against
1 proposal not matched to one resolution
  • Item 1, as a fund house numbered it
    1 for0 against

Mutual fund votes, meeting of 27 Jun 2025, 27 fund houses

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

  • To receive, consider and adopt the Audited Financial Statements (including Consolidated Financial Statements) of the Company for the financial year ended March 31, 2025 together with the Reports of the Board of Directors and Auditors thereon.MoreLess
    26 for0 against
  • To confirm the payment of Interim Dividend on Equity Shares and declare Final Dividend of Rs 42 per share on Equity Shares for the financial year ended March 31, 2025
    27 for0 against
  • To appoint a Director, in place of Mr. Juby Chandy (DIN:09530618), who retires by rotation and being eligible, offers himself for re-appointment.
    27 for0 against
  • Re-Appointment of Dr. (Ms.) Sunita Maheshwari, (DIN 01641411) as an Independent Director
    Against Angel One Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, Helios Mutual Fund, Motilal Oswal Mutual Fund, Navi Mutual Fund, Nippon India Mutual Fund, Zerodha Mutual Fund
    • Angel One Mutual FundPrior approval of shareholders not sought for re-appointment as Independent Director.
    • Edelweiss Mutual Fund, Groww Mutual Fund, Helios Mutual Fund, Motilal Oswal Mutual Fund, Navi Mutual Fund, Zerodha Mutual FundNo concern on the merit of proposed appointee. Non-Compliant with Companies Act: Prior approval of shareholders not sought for re-appointment as ID.
    • Nippon India Mutual FundNon compliant. Prior shareholder approval not sought
    18 for8 against
  • Appointment of Secretarial Auditors of the Company.
    27 for0 against
  • Ratification of Remuneration to Cost Auditor
    27 for0 against
2 proposals not matched to one resolution
  • Item 1, as a fund house numbered it
    1 for0 against
  • Item 4, as a fund house numbered it
    1 for0 against

Mutual fund votes, meeting of 29 Apr 2025, 27 fund houses

  • Re-Appointment of Mr. Juby Chandy (DIN:09530618) as a Whole-time Director & Chief Financial Officer (CFO)
    Against Axis Mutual Fund, Mirae Asset Mutual Fund, Taurus Mutual Fund
    • Axis Mutual Fund, Taurus Mutual FundJuby Chandy, 48, has been the Whole-time Director and Chief Financial Officer since 1 April 2022. His FY24 remuneration aggregated Rs. 65.5 mn which includes value of GSK Plc Share Value Plan: it is unclear if this amount represents fair value of options granted or perquisite value of options exercised. The company has not disclosed his FY25 remuneration. As per the proposed terms, his estimated fixed pay and performance bonus aggregates Rs. 117.5 mn. He is entitled to receive long term incentive under the GSK Plc Share Value Plan (from the parent), for which there is no guidance provided, nor is there an absolute cap. Therefore, we are unable to estimate his overall remuneration for FY26 and FY27. The company must cap overall remuneration in absolute amounts and quantify/disclose the stock options that he is eligible to receive, including the performance metrics which determine such variable pay. It is unclear if he is liable to retire by rotation, however we take comfort from his fixed tenure, after which shareholder approval will be required for his continuation on the board. While we support his reappointment as WTD and CFO, due to lack of adequate disclosures, we are unable to ascertain his aggregate remuneration and hence do not support the resolution.
    • Mirae Asset Mutual FundNeed more disclosure of information relating to remuneration to take informed decision
    24 for3 against
  • Appointment of Mr. Somasundaram Palamadairamaswamy (DIN: 00356363) as an Independent Director
    27 for0 against
  • Appointment of Mr. Anup Wadhawan (Din: 03565167)as an Independent Director
    27 for0 against

Mutual fund votes, meeting of 28 Jun 2024, 24 fund houses

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

  • ORDINARY - To receive, consider and adopt the Audited Financial Statements (including Consolidated Financial Statements) of the Company for the financial year ended 31 March 2024 together with the Reports of the Board of Directors and Auditors thereon.MoreLess
    23 for0 against
  • To declare Rs 32 per share Dividend on Equity Shares for the financial year ended 31 March 2024.
    23 for0 against
  • To appoint a Director in place of Mr. Subesh Williams (DIN: 07786724), who retires by rotation and being eligible, offers himself for re-appointment.
    23 for0 against
  • Appointment of Ms. Renu Sud Karnad as Non- Executive Director (DIN:00008064)
    Against Bandhan Mutual Fund, Baroda BNP Paribas Mutual Fund, Groww Mutual Fund, Helios Mutual Fund, Motilal Oswal Mutual Fund, Zerodha Mutual Fund
    • Bandhan Mutual Fund, Baroda BNP Paribas Mutual Fund, Groww Mutual Fund, Helios Mutual Fund, Motilal Oswal Mutual FundNo concern on merit of proposed appointee. Board is Non-Compliant with Section 152(6) of Companies Act: The Company does not have required retiring directors on the Board.
    • Zerodha Mutual FundContinuation as Non-Retiring Director will lead to continuance of Non-Compliance under Section 152 of the Companies Act,2013.
    17 for6 against
  • Ratification of Remuneration to Cost Auditor.
    23 for0 against
5 proposals not matched to one resolution
  • Item 1, as a fund house numbered it
    1 for0 against
  • Item 2, as a fund house numbered it
    1 for0 against
  • Item 3, as a fund house numbered it
    1 for0 against
  • Item 4, as a fund house numbered it
    1 for0 against
  • Item 5, as a fund house numbered it
    1 for0 against

Mutual fund votes, meeting of 26 Jul 2023, 10 fund houses

  • To receive, consider and adopt the Audited Financial Statements.
    10 for0 against
  • To declare Dividend on Equity Shares for the financial year ended 31 March 2023.
    10 for0 against
  • To appoint a Director in place of Mr. Juby Chandy (DIN:09530618), who retires by rotation and being eligible, offers himself for re-appointment.
    10 for0 against
  • Ratification of Remuneration to Cost Auditor.
    10 for0 against

Mutual fund votes, meeting of 29 Nov 2022, 10 fund houses

  • Appointment of Mr. Bhushan Akshikar (DIN: 09112346) as a Director
    10 for0 against
  • Appointment of Mr. Bhushan Akshikar (DIN: 09112346) as a Managing Director
    10 for0 against

Each fund house counted once, from its own disclosure; the reasons are its own words.

Fines

Reported in the filing for the quarter to Jun 2026.

  • Fine or penaltyCommissioner of CustomsSince 12 Jun 2026

    penalty of Rs. 500/- & Interest amounting Rs.623/- total = Rs 1123/-

    Section 117 of the Customs Act, 1962 read with Rule 18 of the Customs, Central Excise Duties and Service Tax Drawback Rules, 2017

In the company's own words, from its latest governance filing.

Investor complaints and compliance

Quarter by quarter.

Investor complaints received and resolved, the company's own count

  • Received
  • Resolved

Open at the quarter's end

At most 8 complaints open, quarter to Mar 2026.
The board is made up as the listing rules require
Yes
The board has a regular chairperson
Yes
The company has a risk management committee
Yes
The chair is related to the managing director
No
The filing has a part on fines and penalties
Yes
The filing has a part on tax disputes
No
There was a cyber security incident in the quarter
No

The company's own answers in its filing.